---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-060671"
form_type: "8-K"
ticker: "TNGX"
cik: "0001819133"
company_name: "Tango Therapeutics, Inc."
filed_at: "2023-11-08T23:59:59+00:00"
generated_at: "2026-06-08T10:24:06.975821+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Tango Q3 net loss $22.3M; cash $360M into 2026; TNG348 Fast Track

## Summary
- Cash, equivalents and marketable securities $359.9M at Sept 30, 2023; runway into 2026.
- Net loss $22.3M ($0.23/share) vs $29.1M ($0.33/share) in Q3 2022; net loss $71.0M YTD.
- TNG348 (USP1 inhibitor) granted FDA Fast Track for BRCA1/2-mutant cancers; IND cleared; phase 1/2 start expected H1 2024.
- TNG908 (PRMT5) dose escalation ongoing; additional clinical data expected in 2024.
- Kanishka Pothula appointed to Board; Jannik Andersen promoted to CSO; $80M private placement closed in August 2023.

## SEC filing metadata
- accession: 0000950170-23-060671
- form_type: 8-K
- ticker: TNGX
- cik: 0001819133
- company_name: Tango Therapeutics, Inc.
- filed_at: 2023-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819133/000095017023060671/0000950170-23-060671-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819133/000095017023060671/tngx-20231108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-060671
- JSON: https://secwatch.observer/filing/0000950170-23-060671.json
- Plain text: https://secwatch.observer/filing/0000950170-23-060671.txt

## Key facts
- Earnings Releases
  Tango Therapeutics, Inc. reported financial results for third quarter ended September 30, 2023.
  - Period: third quarter ended September 30, 2023
  - Result: reported results
  source text: On November 8, 2023, Tango Therapeutics, Inc. (Tango or the Company) issued a press release relating to its results of operations and financial condition for the quarter ended September 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819133/000095017023060671/0000950170-23-060671-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.